To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets

NCT06426485 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

736

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Toludesvenlafaxine Hydrochloride Sustained-release Tablets
DRUG: placebo

Sponsor

Luye Pharma Group Ltd.